Which drug route is preferably used for administration of analgesics in severe burn patient?

NORCET 5 Prelims - Sept 2023 (Shift-1)

Pharmacology

Hard

Appeared in: NORCET 5 Prelims - Sept 2023 (Shift-1)

Explanation

The intravenous (IV) route is the gold standard for administering analgesics in acute, severe burn patients.
Severe burns cause systemic inflammation, fluid shifts, and peripheral edema, which severely compromise blood flow to muscle and subcutaneous tissues.
The IV route bypasses these compromised tissues, delivering the analgesic directly into the systemic circulation for rapid, predictable, and titratable pain relief, as supported by clinical guidelines for major burn injuries.

Option A: Absorption from intramuscular injections is erratic and unreliable in severe burn patients due to poor perfusion in muscle tissue caused by systemic hypovolemia and edema. This can lead to ineffective pain control or delayed overdose.
Option C: Similar to the IM route, absorption from subcutaneous tissue is unpredictable and impaired by edema and peripheral vasoconstriction in severe burn patients, making it an unsuitable route for acute, severe pain.
Option D: Topical agents provide only localized, superficial anesthesia. They are completely inadequate for managing the deep, intense, and systemic pain characteristic of a severe burn injury.

Visual 1: Diagram: A graph comparing the plasma concentration over time for IV, IM, and oral drug administration, highlighting the rapid peak and predictability of the IV route.
Visual 2: Infographic: The 'Rule of Nines' to illustrate what constitutes a 'severe' burn, providing context for the systemic effects on the body.

Clinical Relevance

Nursing practice connection: Use the key finding related to Pharmacokinetics and Pain Management in Burn Patients to guide bedside assessment, documentation, and the next nursing action.
A nurse's primary role is to accurately assess pain using an appropriate scale (like the CPOT for non-verbal patients) and advocate for and administer IV analgesia as prescribed to prevent the severe physiological and psychological stress of uncontrolled pain.
Nurses must continuously monitor the patient's respiratory rate, oxygen saturation, and level of consciousness for signs of opioid-induced respiratory depression, especially given the high doses often required in burn patients.
What if? If a patient with a severe burn has no available IV access in an emergency, the next best route is Intraosseous (IO). The IO route provides access to the bone marrow's venous plexus, acting as a non-collapsible vein for rapid drug and fluid administration.

How to Approach the Question

First, identify the patient's condition: 'severe burn patient'. This is the most critical clue.
Next, recall the pathophysiology of a severe burn: systemic inflammatory response, massive fluid shifts, edema, and compromised peripheral circulation.
Then, evaluate each drug route based on this pathophysiology. Ask yourself: 'How will drug absorption be affected by poor tissue perfusion and edema?'
Eliminate routes with unreliable absorption (IM, SC) because the drug won't reach the bloodstream predictably.
Eliminate routes with an insufficient area of effect (Topical) for severe, systemic pain.
Conclude that the route that bypasses absorption issues and provides direct, rapid systemic access (IV) is the only logical and safe choice.

Concept Tested & Keywords

Concept Tested: Pharmacokinetics and Pain Management in Burn Patients
Stem keywords: drug route, analgesics, severe burn patient
Lead-in keywords: preferably used
Clinical cues: The term 'severe burn' is a critical cue, indicating systemic physiological changes like fluid shifts and poor perfusion, which directly impact drug absorption.
Negative lead-in flag: false

QCcSkaubfi-hJlLGsH_LzU